{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:35:35Z","timestamp":1791599735536,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.radonc.2026.111478","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:23:24Z","timestamp":1772925804000},"page":"111478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Multiparametric MRI assessment of 6-month Post-Treatment response following Real-Time adaptive stereotactic body radiotherapy for prostate cancer: Correlation with Post-Treatment PSA kinetics"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-8369","authenticated-orcid":false,"given":"Sungmin","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-6496","authenticated-orcid":false,"given":"Anton S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebert Alberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-3414","authenticated-orcid":false,"given":"Angela","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Charbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Leithner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8786-8686","authenticated-orcid":false,"given":"Marius E.","family":"Mayerhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-0933","authenticated-orcid":false,"given":"Peter B.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8244-8646","authenticated-orcid":false,"given":"Jeffrey D.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Zelefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111478_b0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rcl.2023.06.013","article-title":"Evaluation of Prostate Cancer Recurrence with MR Imaging and Prostate Imaging for Recurrence Reporting Scoring System","volume":"62","author":"Pecoraro","year":"2024","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.radonc.2026.111478_b0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.euo.2022.02.005","article-title":"Local failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion","volume":"6","author":"Gorovets","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2026.111478_b0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2214\/AJR.19.21836","article-title":"Prognostic Value of Pretreatment MRI in patients with Prostate Cancer Treated with Radiation Therapy: a Systematic Review and Meta-Analysis","volume":"214","author":"Woo","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.radonc.2026.111478_b0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the Intraprostatic Tumor in External Beam Radiotherapy for patients with Localized Prostate Cancer: results from the FLAME Randomized phase III Trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00345-023-04745-w","article-title":"Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review","volume":"42","author":"Dornisch","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.radonc.2026.111478_b0035","doi-asserted-by":"crossref","unstructured":"Draulans C, Haustermans K, Pos FJ, van der Heide UA, De Cock L, van der Voort van Zyp J, et al. Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial. Radiother Oncol. 2024 Dec;201:110568.","DOI":"10.1016\/j.radonc.2024.110568"},{"key":"10.1016\/j.radonc.2026.111478_b0040","article-title":"Dose Intensification to the Dominant Intraprostatic Lesion during Prostate Stereotactic Body Radiation Therapy Delivered on a magnetic Resonance Imaging Linear Accelerator: Feasibility and Early Clinical Outcomes","volume":"10","author":"Zelefsky","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0045","article-title":"Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity","volume":"54","author":"Gurewitz","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0050","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1007\/s00330-025-11358-x","article-title":"Discordance between prostate MRI and PSMA-PET\/CT: the next big challenge for primary prostate tumor assessment?","volume":"35","author":"Woo","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2026.111478_b0055","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1007\/s00261-025-04948-2","article-title":"Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET\/CT","volume":"50","author":"Woo","year":"2025","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.radonc.2026.111478_b0060","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based guidelines on Multiparametric magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0065","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/mp.15130","article-title":"Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy","volume":"49","author":"Wang","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111478_b0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ucl.2018.03.011","article-title":"Prostate MR Imaging for Posttreatment Evaluation and Recurrence","volume":"45","author":"Gaur","year":"2018","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.radonc.2026.111478_b0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2019.04.003","article-title":"Early biochemical predictors of survival in intermediate and high-risk prostate cancer treated with radiation and androgen deprivation therapy","volume":"140","author":"Patel","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0080","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.diii.2019.06.003","article-title":"Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI)","volume":"100","author":"Wu","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.radonc.2026.111478_b0085","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210683","article-title":"MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. results of a phase II trial","author":"Zapatero","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2026.111478_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.mri.2025.110431","article-title":"Longitudinal quantitative MRI in prostate cancer after radiation therapy with and without androgen deprivation therapy","volume":"122","author":"Wang","year":"2025","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2026.111478_b0095","article-title":"Multiparametric MRI as a Predictor of PSA Response in patients Undergoing Stereotactic Body Radiation Therapy for Prostate Cancer","volume":"9","author":"Rayn","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/RLI.0b013e3181b4c10e","article-title":"Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla","volume":"44","author":"Gibbs","year":"2009","journal-title":"Invest Radiol"},{"key":"10.1016\/j.radonc.2026.111478_b0105","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233055","article-title":"The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker","volume":"313","author":"Boss","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2026.111478_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijrobp.2025.04.039","article-title":"PSMA MRI Guided prOstate SBRT (ARGOS)\/Comprehensive, Longitudinal Evaluation of IMaging BiomarkErs Post Radiotherapy (CLIMBER) phase I\/II Trial","volume":"123","author":"Ramadan","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111478_b0115","article-title":"Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: a Review and Clinical Trial Protocol","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13014-024-02440-7","article-title":"Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial","volume":"19","author":"Zapatero","year":"2024","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13014-018-1182-z","article-title":"Long-term results and PSA kinetics after robotic SBRT for prostate cancer: multicenter retrospective study in Korea (korean radiation oncology group study 15-01)","volume":"13","author":"Park","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111478_b0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/annonc\/mdp365","article-title":"Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy","volume":"21","author":"de Crevoisier","year":"2010","journal-title":"Ann Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:05:36Z","timestamp":1789751136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S0167814026001179"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111478","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparametric MRI assessment of 6-month Post-Treatment response following Real-Time adaptive stereotactic body radiotherapy for prostate cancer: Correlation with Post-Treatment PSA kinetics","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111478"}}